← back to search

Patricia Hartge

Division of Cancer Epidemiology and Genetics · US
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Ovarian cancer diagnosis and treatment, Cancer Risks and Factors, and Pancreatic and Hepatic Oncology Research.
h-index
108
citations
46,163
works
520
NIH funding
primary concept
email

Recent publications

Association of tea and coffee consumption and biliary tract cancer risk: The Biliary Tract Cancers Pooling Project
Hepatology 2023cited by 9position: middledoi
Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia
Journal of Clinical Oncology 2022cited by 30position: middledoi
Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies
American Journal of Clinical Nutrition 2021cited by 39position: middledoi
The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3)
Cancer Research 2020cited by 60position: middledoi
Associations between reproductive factors and biliary tract cancers in women from the Biliary Tract Cancers Pooling Project
Journal of Hepatology 2020cited by 34position: middledoi
Endogenous estradiol and inflammation biomarkers: potential interacting mechanisms of obesity-related disease
Cancer Causes & Control 2020cited by 24position: middledoi
Genome-Wide Gene–Diabetes and Gene–Obesity Interaction Scan in 8,255 Cases and 11,900 Controls from PanScan and PanC4 Consortia
Cancer Epidemiology Biomarkers & Prevention 2020cited by 10position: middledoi
Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk
Cancer Research 2020cited by 9position: middledoi
A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer
Queensland's institutional digital repository (The University of Queensland) 2020cited by 0position: middle
A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer
JNCI Journal of the National Cancer Institute 2019cited by 91position: middledoi
High Levels of C-Reactive Protein Are Associated with an Increased Risk of Ovarian Cancer: Results from the Ovarian Cancer Cohort Consortium
Cancer Research 2019cited by 73position: middledoi
Anthropometric Risk Factors for Cancers of the Biliary Tract in the Biliary Tract Cancers Pooling Project
Cancer Research 2019cited by 45position: middledoi
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer
Nature Communications 2018cited by 278position: middledoi
Antibodies Against <i>Chlamydia trachomatis</i> and Ovarian Cancer Risk in Two Independent Populations
JNCI Journal of the National Cancer Institute 2018cited by 92position: middledoi
Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium
JNCI Journal of the National Cancer Institute 2018cited by 59position: middledoi
Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium
International Journal of Cancer 2018cited by 50position: middledoi
HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes
Cancer Research 2018cited by 41position: middledoi
Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer
JNCI Journal of the National Cancer Institute 2018cited by 27position: middledoi
Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium
Obstetrical & Gynecological Survey 2018cited by 5position: middledoi
Abstract 4942: Serologic markers of infectious agents and ovarian cancer: Markers of prior <i>Chlamydia trachomatis</i> infection associated with increased ovarian cancer risk in two independent populations
Cancer Research 2018cited by 1position: middledoi
Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148
Nature Communications 2017cited by 54position: middledoi
Body Size Indicators and Risk of Gallbladder Cancer: Pooled Analysis of Individual-Level Data from 19 Prospective Cohort Studies
Cancer Epidemiology Biomarkers & Prevention 2017cited by 52position: middledoi
Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma
Lupus Science & Medicine 2017cited by 27position: middledoi
Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults
JAMA Internal Medicine 2016cited by 1,477position: middledoi
Anthropometric Factors and Thyroid Cancer Risk by Histological Subtype: Pooled Analysis of 22 Prospective Studies
Thyroid 2016cited by 193position: middledoi
Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia
Nature Communications 2016cited by 119position: middledoi
Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes
Human Molecular Genetics 2016cited by 59position: middledoi
Leisure Time Physical Activity and Mortality
JAMA Internal Medicine 2015cited by 1,469position: middledoi
Smoking and Mortality — Beyond Established Causes
New England Journal of Medicine 2015cited by 812position: middledoi
Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies
Annals of Oncology 2015cited by 154position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Alpa V. Patel · American Cancer Society4 papers (2012–2015)Susan M. Gapstur · Tiffin University4 papers (2012–2014)Britton Trabert · University of Utah4 papers (2018–2020)Amy Berrington de González · Institute of Cancer Research4 papers (2012–2015)Yikyung Park · Washington University in St. Louis4 papers (2012–2014)Nicolas Wentzensen · National Cancer Institute4 papers (2018–2020) · 3 papers (2012–2015)Charles E. Matthews · 3 papers (2012–2015)Louise A. Brinton · Division of Cancer Epidemiology and Genetics3 papers (2018–2020)Elisabete Weiderpass · World Health Organization3 papers (2012–2015)Kala Visvanathan · Johns Hopkins University3 papers (2012–2019)Steven C. Moore · New York University3 papers (2012–2015)Jolanta Lissowska · National Institute of Oncology2 papers (2018–2018)Mark E. Sherman · Nemours Children’s Clinic2 papers (2018–2018)Beata Pepłońska · Nofer Institute of Occupational Medicine2 papers (2018–2018) · 2 papers (2018–2019) · 2 papers (2018–2018)Ruth M. Pfeiffer · National Institutes of Health2 papers (2013–2020)Cari M. Kitahara · National Institutes of Health2 papers (2014–2014)Martha S. Linet · Center for Cancer Research2 papers (2012–2015)